Filter
800
Text search:
National
Medicines
Regulatory
Authority
Featured
Recommendations
82
New Publications
259
Language
Document type
No document type
414
Guidelines
131
Studies & Reports
127
Manuals
53
Strategic & Response Plan
41
Fact sheets
13
Situation Updates
8
Training Material
5
Brochures
3
Resource Platforms
3
Infographics
1
Online Courses
1
Countries / Regions
Kenya
41
Uganda
35
Ethiopia
34
India
26
South Africa
25
Liberia
21
Nigeria
21
Ghana
21
Zambia
21
Tanzania
21
Global
18
Rwanda
16
Bangladesh
14
Western and Central Europe
14
Malawi
13
Ukraine
13
Sierra Leone
12
Myanmar / Burma
12
Nepal
11
Zimbabwe
10
Namibia
9
Latin America and the Carribbean
9
Africa
9
Syria
7
Philippines
6
Eswatini/ Swaziland
6
Botswana
6
Lesotho
6
Eastern Europe
6
Guinea
5
Pakistan
5
Cambodia
5
Indonesia
5
Asia
5
Sudan
4
South–East Asia Region
4
Congo, Democratic Republic of
3
Cameroon
3
Somalia
3
Jordan
3
Eastern Europe and Central Asia
3
Albania
3
Georgia
3
Senegal
2
Haiti
2
Afghanistan
2
Thailand
2
Papua New Guinea
2
Benin
2
West and Central Africa
2
Middle East and North Africa
2
Laos
2
Morocco
1
USA
1
Saudi Arabia
1
Iraq
1
Lebanon
1
Chad
1
Mozambique
1
North Macedonia
1
Ecuador
1
Greece
1
Libya
1
Sri Lanka
1
East and Southern Africa
1
Western Pacific Region
1
Paraguay
1
Fiji
1
Timor Leste/ East Timor
1
Qatar
1
Moldova
1
Iran
1
Australia
1
Vietnam
1
Gabon
1
Denmark
1
Maldives
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Countries
395
Clinical Guidelines
50
Public Health
35
Pharmacy & Technologies
25
Women & Child Health
16
Key Resources
16
Capacity Building
6
Toolboxes
AMR
94
Pharmacy
94
COVID-19
52
HIV
40
TB
40
Mental Health
21
Rapid Response
17
Global Health Education
14
Caregiver
14
Ebola
13
Planetary Health
11
Conflict
10
NCDs
9
Refugee
8
Natural Hazards
5
NTDs
5
Disability
4
Specific Hazards
4
Polio
3
Zika
3
Health Financing Toolbox
3
Cholera
1
Prices people pay for medicines.
Pakistan Global Antibiotic Resistance Partnership (GARP) was formed in the wake of international and national efforts for AMR curtailment. A group of experts from microbiology, infectious diseases and veterinary medicine
...
Notable progress has also been made on other key health indicators such as reducing maternal, infant and child deaths and malnutrition, increasing immunization coverage, eliminating infectious diseases such as polio and reducing the incidence of malaria, tuberculosis and diarrhoeal diseases.
But
...
UGANDA NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME
The Global vector control response 2017–2030 (GVCR) provides a new strategy to strengthen vector control worldwide through increased capacity, improved surveillance, better coordination and integrated action across sectors and diseases.
In May 2017, the World Health Assembly adopted resolutio ...
In May 2017, the World Health Assembly adopted resolutio ...
Antimicrobials are medicines, including antibiotics, antivirals, antifungals, and antiparasitics, that are used to prevent and treat infections in humans, animals, and plants. Antimicrobial Resistance (AMR) arises when bacteria, viruses, fungi, and
...
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the vi
...
This guide is intended to support national governments developing their national deployment and vaccination plans (NDVPs) for COVID-19 vaccines by outlining the roles, needs and opportunities for co
...
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
Global UNIDO Project: Strengthening the local production of essential medicines in least developed and developing countries
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation
...
This field study to assess the pharmaceutical situation was undertaken in Ghana in May-June 2008 using a standardized methodology developed by the World Health Organization. The study assessed medicines availability and affor
...
WHO Model Formulary for Children
recommended
WHO Model Formulary for children based on the Second Model List of Essential Medicines for Children 2009.
In 2007, the World Health Assembly passed a Resolution titled ‘Better Medicines for Chil
...
The manufacturing process is one of the key steps where quality control is required to ensure quality of medicinal products, including herbal medicines. Good manufacturing practices (GMP) is one of the most important tools for this measure.
The objectives of the meeting were to agree on coordinated and aligned support to the 3 countries’ national health recovery plans (Guinea, Liberia, Sierra Leone); to identify cross-cutting areas and opportunities for integration; to identify ways
...
The country profiles incorporate facts indicating the national status of medical devices in areas such as: medical device policies, regulations, incorporation, lists, inventories, nomenclature, health technology assessment, management, and biomedi
...
The aim of the Annual Inspection Report is to present findings of public sector health establishments inspected by the OHSC to monitor compliance with the National Core Standards (NCS) during the 2016/2017 financial year in South Africa.
The NCS de
...
The International Pharmaceutical Federation (FIP) is a global federation of national associations of pharmacists and
pharmaceutical scientists. In order to support these associations in their fight against AMR, FIP has prepared this
briefing docum
...
Communication to Healthcare Professionals Mar-2020
This guideline is intended to assist healthcare professionals in the participation of very important process of continuous surveillance of safety and efficacy of the health products which are used in their clinical practice. Continuous evaluation o
...
Member States have requested WHO policy guidance on how to facilitate the implementation of national AMS activities in an integrated and programmatic approach. This policy guidance responds to that demand from Member States and is anchored in public
...
